P
Pelthos Therapeutics Inc. (PTHS)
ASE – Real Time Price. Currency in USD
29.03
-0.18 (-0.62%)
At close: Jun 26, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
29.03
-0.18 (-0.62%)
At close: Jun 26, 2026, 4:00 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.76 | 6.05 | 10 | |
| Quick ratio | 1.83 | 5.63 | 9.0 | |
| Debt to Equity | 1.51 | 0.30 | 5.0 | |
| Debt to Assets | 0.36 | 1.04 | 6.0 | |
| Interest coverage | -5.56 | -16.91 | 1.0 | |
| Weighted average score | 6.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | 17M | 28M |
| Gross Profit | N/A | N/A | N/A | 11M | 18M |
| Operating Income | -2M | -7M | -8M | -32M | -44M |
| Net Income | -2M | -7M | -8M | -43M | -52M |
| EBITDA | -2M | -7M | -8M | -30M | -40M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 47.61 | 5.5 |
| Next quarter | 148.69 | 59.33 | 10 |
| Current year | 279.71 | 55.07 | 10 |
| Next year | 84.33 | 83.89 | 10 |
| Weighted average score | 8.9 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 16.16 | 52.74 | 55.02 | -109.72 | 7.5 |
| Y/Y | 999 | -420.32 | 3.74 | -2007.15 | 4.0 |
| 3y average | 999 | -217.48 | N/A | -248.23 | 3.3 |
| 5y average | 779.2 | -191.1 | N/A | -137.4 | 3.3 |
| Weighted average score | 4.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $52.9M significantly exceeds cash reserves ($32.2M), raising financial stability concerns
Total current assets $69.1M exceed Total current liabilities $25.0M, highlighting excellent liquidity
Debt-to-equity ratio (1.5) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (-5.6x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$13.3M limits the company's ability to reinvest or pay down debt